Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006.
Although the incidence of hospitalizations with infection due to vancomycin-resistant pathogens in the United States remained stable during 2000-2003, it increased from 4.60 to 9.48 hospitalizations per 100,000 population during 2003-2006. Hospitalizations with infection due to vancomycin-resistant pathogens also increased as a proportion of all US hospitalizations, from 3.16 to 6.51 hospitalizations with VRE infection per 10,000 total hospitalizations during 2003-2006. The number of hospitalizations with infection due to vancomycin-resistant pathogens is increasing in the United States. Because infection due to vancomycin-resistant organisms is associated with poor outcomes, the epidemiology of this trend needs further exploration.
Ramsey
Andrew M
AM
School of Public Health and Health Sciences, University of Massachusetts, Amherst, Massachusetts, USA.
Zilberberg
Marya D
MD
D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D016983:Enterococcus / Q000187:drug effects* / Q000302:isolation & purification; D016908:Gram-Positive Bacterial Infections / Q000453:epidemiology* / Q000382:microbiology; D006760:Hospitalization / Q000706:statistics & numerical data / Q000639:trends*; D006801:Humans; D015994:Incidence; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D014481:United States / Q000453:epidemiology; D014640:Vancomycin / Q000494:pharmacology; D020713:Vancomycin Resistance; D055815:Young Adult
D000900:Anti-Bacterial Agents; D014640:Vancomycin